Bevacizumab in High-Risk Corneal Transplantation is a research paper published in Ophthalmology (2022). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NEI NIH HHS
Grant: K08 EY031340
NEI NIH HHS
Grant: K08 EY031759
NEI NIH HHS
Grant: K12 EY016335
NEI NIH HHS
Grant: R01 EY030283
FWCI
3.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals